跳转至内容
Merck
CN
  • Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib.

Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib.

Journal of the National Cancer Institute (2015-11-14)
Victor Wong, Dean Pavlick, Tim Brennan, Roman Yelensky, John Crawford, Jeffrey S Ross, Vincent A Miller, Denise Malicki, Philip J Stephens, Siraj M Ali, Hyunah Ahn